HBT
CATX icon

Hills Bank & Trust’s Perspective Therapeutics CATX Stock Holding History

Hills Bank & Trust’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Hold
872,200
– – 0.13% 91
2026
Q1 		$3.64M Sell
872,200
-66,000
-7% -$279K 0.18% 65
2025
Q4 		$2.58M Sell
938,200
-41,000
-4% -$117K 0.15% 84
2025
Q3 		$3.36M Sell
979,200
-5,000
-0.5% -$18.2K 0.2% 70
2025
Q2 		$3.39M Sell
984,200
-39,428
-4% -$104K 0.21% 69
2025
Q1 		$2.18M Sell
1,023,628
-4,202
-0.4% -$12.6K 0.15% 89
2024
Q4 		$3.28M Hold
1,027,830
– – 0.25% 65
2024
Q3 		$13.7M Buy
+1,027,830
New +$13.7M 1.04% 21
2024
Q2 		– Sell
-1,035,831
Closed -$12.3M – 289
2024
Q1 		$12.3M Buy
+1,035,831
New +$8.83M 1.05% 22

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Hills Bank & Trust's CATX Position: Q2 2026 in Review

Hills Bank & Trust held its Perspective Therapeutics (CATX) position steady in Q2 2026 at 872,200 shares worth $2.97M. The position accounts for 0.13% of the portfolio, ranked #91.

Hills Bank & Trust first reported a position in CATX in Q1 2024 and has held it in 9 quarters since. The position peaked at $13.7M in Q3 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Hills Bank & Trust held 872,200 shares of Perspective Therapeutics worth $2.97M as of Q2 2026.
  • Hills Bank & Trust left its Perspective Therapeutics share count unchanged in Q2 2026.
  • Perspective Therapeutics made up 0.13% of Hills Bank & Trust's portfolio in Q2 2026, its #91 holding.
  • Hills Bank & Trust first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Hills Bank & Trust's Perspective Therapeutics position peaked at $13.7M in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Hills Bank & Trust's 13F filing for Q2 2026, filed 10 Aug 2026.